Evaluation of the highly sensitive chemiluminescent enzyme immunoassay "Lumipulse HBsAg-HQ" for hepatitis B virus screening.

Matsuo DeguchiMasanori KagitaNori YoshiokaHiroko TsukamotoMiyuki TakaoKazuko TaharaIkuhiro MaedaYoh HidakaSatoshi YamauchiAtsushi KanekoHideo MiyakoshiMitsuo Isomura

Published in: Journal of clinical laboratory analysis (2017)

According to these results, the Lumipulse HBsAg-HQ assay, with a highly sensitive limit of detection of 0.005 IU/mL, may facilitate the development of a better management strategy for a considerable proportion of infected patients.

Keyphrases

hepatitis b virus
label free
fluorescent probe
liver failure
molecularly imprinted
high throughput
living cells
loop mediated isothermal amplification
sensitive detection
real time pcr